Results 241 to 250 of about 12,926,306 (256)

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Cell, 2018
Jedd D. Wolchok, F Stephen Hódi, Bastian Schilling   +2 more
exaly  

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell, 2017
Alexandria P. Cogdill, James P. Allison, Spencer C Wei   +2 more
exaly  

PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways

Immunity, 2019
Xiaozheng Xu, Enfu Hui, Changchun Xiao
exaly  

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

Cell, 2016
Chantale Bernatchez, Jianjun Gao, Andrew Futreal   +2 more
exaly  

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

Cell Research, 2018
Pan Zheng, Juanjuan Su, Peng Zhang
exaly  

Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood

Proceedings of the National Academy of Sciences of the United States of America, 2016
Katrin Klocke, Kajsa Wing, Shimon Sakaguchi   +2 more
exaly  

Anti–CTLA-4 therapy requires an Fc domain for efficacy

Proceedings of the National Academy of Sciences of the United States of America, 2018
Scott J Garforth, Stephanie K Dougan, Michael Dougan   +2 more
exaly  

Treg and CTLA-4: Two intertwining pathways to immune tolerance

Journal of Autoimmunity, 2013
Lucy Walker
exaly  

Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation

Journal of Biological Chemistry, 2012
David M Sansom, Stephen J. Royle, Satdip Kaur   +2 more
exaly  

Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation

Genes and Immunity, 2013
Heather M Gibson
exaly